Liver Diseases Therapeutics Market Size, Share and Growth 2015

1
www.hexareports.com
v
Global Liver Diseases Therapeutics Market Size
and Share, Growth, Market Price, Analysis,
Forecast and Overview 2015 - 2019
Category Pharmaceutical
2
Report Overview

• Liver diseases are of different types such as
  hepatitis, liver cancer, non-alcoholic fatty
  liver disease, and liver cirrhosis. Hepatitis is
  the largest segment among these diseases, of
  which hepatitis C is the biggest and fastest
  growing segment. The liver diseases caused by
  viral infections, alcoholism, obesity, diabetes,
  among many other reasons.
• Some of the diseases are not curable such as
  liver cirrhosis or non-alcoholic fatty liver
  disease, and are usually not diagnosed early.
  This leads to the substantial damage of the
  liver, which proves to be life-threatening. Some
  types of hepatitis are preventable or treatable
  by using vaccines and indicated drugs.
• Technavio's analysts forecast the global liver
  diseases therapeutics market to grow at a CAGR of
  15.61 over the period 2014-2019.

www.hexareports.com
3
Covered in this report

• This report covers the present scenario and the
  growth prospects of the global liver diseases
  therapeutics market for 2015-2019. To calculate
  the market size, the report considers revenue
  generated from the sales of various off-label and
  branded drugs and the expected launch of drug
  candidates intended to be used in the treatment
  of liver diseases.
• Based on disease indication, the market is
  segmented as follows
• Non-alcoholic fatty liver disease (includes
  non-alcoholic steatohepatitis)
• Liver cirrhosis
• Liver cancer
• Hepatitis (Hepatitis A, B, and C)
• This report includes a discussion of the market
  in the following three regions
• Americas The major countries focused in the
  Americas are the US, Canada, Mexico, and Brazil
• EMEA The major countries in this region are the
  UK, Germany, Italy, France, Spain and Middle
  Easternand African countries such as Israel,
  South Africa, Egypt, Sudan, Kuwait, Saudi Arabia,
  Qatar, and the UAE
• APAC The major countries in this region are
  Japan, China, Australia, Singapore, South Korea,
  and India.

www.hexareports.com
4
Other prominent vendors

• AbbVie
• Achillion Pharmaceuticals
• Advinus
• Angion Biomedica
• AstraZeneca
• Bayer
• BiOrion
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Celsion
• Conatus
• Digna Biotech
• Dynavax Technologies
• Eli Lilly
• Galectin Therapeutics
• LG Life Sciences

www.hexareports.com
5
Key market

• Key market driver
• Increased prevalence of liver diseases
• For a full, detailed list, view our report
• Key market challenge
• Multiple patent expiries
• For a full, detailed list, view our report
• Key market trend
• Growing public awareness
• For a full, detailed list, view our report
• Key questions answered in this report
• What will the market size be in 2019 and what
  will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats
  faced by the key vendors?

www.hexareports.com
6
Thank You!
For More Details
http//www.hexareports.com/report/global-liver-dis
eases-therapeutics-market/details
Stay With US
Global Head Quarters Felton Office Plaza, 6265
Highway 9, Felton, California, 95018, ?United
States.
E-mail sales_at_hexareports.com
Telephone Direct
1-800-489-3075